A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

NCT00833781 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection
HIV Infections

Interventions

BIOLOGICAL: mRNA-transfected autologous dendritic cells
BIOLOGICAL: autologous dendritic cells with no mRNA transfection

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]